Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CH Biotech R&D CoTPE:6534 +0.22%91 5-Year Yield-on-Cost % is 43.80 as of Jul. 29, 2026, which is 18% above its 10-year median of 37.22. GuruFocus rates TPE:6534 with a GF Score™ of 91/100 and a GF Value™ of NT$100.97 (Fairly Valued). The stock has 1 warning sign investors should review. Among 148 Agriculture companies, CH Biotech R&D Co ranks better than 95.95% on this metric.
CH Biotech R&D Co's yield on cost for the quarter that ended in Dec. 2025 was 43.80.
The historical rank and industry rank for CH Biotech R&D Co's 5-Year Yield-on-Cost % or its related term are showing as below:
TPE:6534'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 10.3 Med: 37.22 Max: 51.31
Current: 43.8
During the past 13 years, CH Biotech R&D Co's highest Yield on Cost was 51.31. The lowest was 10.30. And the median was 37.22.
TPE:6534's 5-Year Yield-on-Cost % is ranked better than 95.95% of 148
companies
in the Agriculture industry
Industry Median: 3.445
vs TPE:6534: 43.80
CH Biotech R&D Co (TPE:6534) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
CH Biotech R&D Co 5-Year Yield-on-Cost % Related Terms
TPE:6534 vs CTVA, CF, MOS: 5-Year Yield-on-Cost % Comparison
For the Agricultural Inputs subindustry, CH Biotech R&D Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CH Biotech R&D Co 5-Year Yield-on-Cost % vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, CH Biotech R&D Co's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where CH Biotech R&D Co's 5-Year Yield-on-Cost % falls into.
CH Biotech R&D Co 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
CH Biotech R&D Co (TPE:6534) has a 5-Year Yield-on-Cost % of 43.80 as of Jul. 29, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on CH Biotech R&D Co and its competitors. This is 18% above median its historical median of 37.22. Over the past decade, CH Biotech R&D Co's 5-Year Yield-on-Cost % has ranged from 10.30 to 51.31. According to the industry distribution chart, CH Biotech R&D Co ranks #6 out of 148 companies in the Agriculture industry, placing it in the top 4.1%.
Is CH Biotech R&D Co's 5-Year Yield-on-Cost % too high?
CH Biotech R&D Co's current 5-Year Yield-on-Cost % of 43.80 is 18% above median its 10-year median of 37.22. Over the past 10 years, this metric has ranged from a low of 10.30 to a high of 51.31. The Agriculture industry median 5-Year Yield-on-Cost % is 3.45. CH Biotech R&D Co's value of 43.80 is 1171.4% above this industry median. Based on the distribution chart, CH Biotech R&D Co ranks #6 out of 148 companies in the Agriculture industry, which is in the top quartile — a strong position relative to peers. Overall, CH Biotech R&D Co has a GF Score™ of 91/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does CH Biotech R&D Co's 5-Year Yield-on-Cost % compare to CTVA and CF?
According to the Agriculture industry distribution chart, CH Biotech R&D Co ranks #6 out of 148 companies for 5-Year Yield-on-Cost %. This places CH Biotech R&D Co in the top 4% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 3.45. CH Biotech R&D Co's value of 43.80 is 1171.4% above this benchmark. Historically, CH Biotech R&D Co's own 5-Year Yield-on-Cost % has ranged from 10.30 to 51.31 over the past decade. While the company's 10-year median is 37.22 vs. the industry median of 3.45, CH Biotech R&D Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for an Agriculture company?
The median 5-Year Yield-on-Cost % among Agriculture companies is 3.45, based on 148 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CH Biotech R&D Co's current 5-Year Yield-on-Cost % of 43.80 is 1171.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on CH Biotech R&D Co and its competitors. For the Agriculture industry, the median 5-Year Yield-on-Cost % is 3.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CH Biotech R&D Co's current 5-Year Yield-on-Cost % is 43.80, which is 18% above median its own 10-year median of 37.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CH Biotech R&D Co stock overvalued right now?
Based on GuruFocus' analysis, CH Biotech R&D Co (TPE:6534) is currently considered Fairly Valued. The stock's GF Value™ is NT$100.97, compared to a current price of NT$92.70 — trading 8.2% below its estimated fair value. The current 5-Year Yield-on-Cost % is 43.80, which is 18% above median its 10-year median of 37.22 and 1171.4% above the Agriculture industry median of 3.45. CH Biotech R&D Co's overall GF Score™ is 91/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For CH Biotech R&D Co (TPE:6534), the current 5-Year Yield-on-Cost % is 43.80 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CH Biotech R&D Co (TPE:6534) Overvalued in 2026?
Based on GuruFocus' analysis, CH Biotech R&D Co stock appears to be undervalued.
The current stock price of NT$92.70 is trading 8.2% below its estimated GF Value™ of NT$100.97.
GuruFocus considers CH Biotech R&D Co to be Fairly Valued.
Key valuation signals for TPE:6534:
5-Year Yield-on-Cost %: 43.80 (18% above median its 10-year median of 37.22)
GF Value™: NT$100.97 vs. price of NT$92.70 (8.2% below fair value)
Industry Position: 1171.4% above the Agriculture median (#6 of 148)
No single metric tells the full story. See the TPE:6534 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CH Biotech R&D Co Ltd is a Taiwan-based company engaged in the manufacture and sales of fertilizer, as well as providing biotechnology services. It is engaged in the research, development, manufacturing, and sales of proprietary plant growth regulators and specialty micronutrient fertilizers. It offers NutriSync 3D plant growers in the form of boron and molybdenum, NutriSync D liquid formulation for dicot crops, CHB-HS for reducing carbon emissions in crop production, CHB-BB2, fruit quality enhancers, and other related products. The company has one reportable segment, Agricultural Biotechnology. Geographically, it derives maximum revenue from the United States, and the rest from other countries.
91GF Score
Get the complete analysis for TPE:6534
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6534 has been successfully added to your 
